welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
- Outcome Based on Management for Duodenal Adenomas: Sporadic versus Familial DiseaseINTRODUCTION : Management and outcomes f...
- Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis PatientsThe purpose of this study is to assess i...
- Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Cl...IMPORTANCE: Patients with familial aden...
- Inherited Colorectal Cancer Syndromes – Diagnosis and ManagemntColorectal cancer is the most common gas...
- Coping and relaxation techniques with medical procedureshttps://www.youtube.com/watch?v=_tUhIYzA...
- The J-Pouch Group Dietary GuidelinesGood nutrition plays an essential role i...
- Limitless FAP Cliphttps://www.youtube.com/watch?v=aoVWdnB3...
English
Portuguese
Spanish